Xia J, Li Chunbo
University of Leeds, Department of Psychiatry and Behavioural Sciences, 15-19 Hyde Terrace, Leeds, UK, LS2 9LT.
Cochrane Database Syst Rev. 2007 Apr 18;2007(2):CD006365. doi: 10.1002/14651858.CD006365.pub2.
The severe and long-lasting symptoms of schizophrenia are often the cause of severe disability. Environmental stress such as life events and the practical problems people face in their daily can worsen the symptoms of schizophrenia. Deficits in problem solving skills in people with schizophrenia affect their independent and interpersonal functioning and impair their quality of life. As a result, therapies such as problem solving therapy have been developed to improve problem solving skills for people with schizophrenia.
To review the effectiveness of problem solving therapy compared with other comparable therapies or routine care for those with schizophrenia.
We searched the Cochrane Schizophrenia Group's Register (September 2006), which is based on regular searches of BIOSIS, CENTRAL, CINAHL, EMBASE, MEDLINE and PsycINFO. We inspected references of all identified studies for further trials.
We included all clinical randomised trials comparing problem solving therapy with other comparable therapies or routine care.
We extracted data independently. For homogenous dichotomous data we calculated random effects, relative risk (RR), 95% confidence intervals (CI) and, where appropriate, numbers needed to treat (NNT) on an intention-to-treat basis. For continuous data, we calculated weighted mean differences (WMD) using a random effects statistical model.
We included only three small trials (n=52) that evaluated problem solving versus routine care, coping skills training or non-specific interaction. Inadequate reporting of data rendered many outcomes unusable. We were unable to undertake meta-analysis. Overall results were limited and inconclusive with no significant differences between treatment groups for hospital admission, mental state, behaviour, social skills or leaving the study early. No data were presented for global state, quality of life or satisfaction.
AUTHORS' CONCLUSIONS: We found insufficient evidence to confirm or refute the benefits of problem solving therapy as an additional treatment for those with schizophrenia. The small number of participants, the quality of reporting of methods and results were of concern. More trials with adequate reporting of methods to minimize bias, adequately powered, with validated, reliable and clinically meaningful outcomes are needed to provide robust evidence to guide policy and practice.
精神分裂症严重且持久的症状往往是导致严重残疾的原因。诸如生活事件等环境压力以及人们在日常生活中面临的实际问题会加重精神分裂症的症状。精神分裂症患者解决问题能力的缺陷会影响他们的独立功能和人际交往功能,并损害他们的生活质量。因此,已经开发出诸如解决问题疗法等治疗方法来提高精神分裂症患者的解决问题能力。
比较解决问题疗法与其他类似疗法或常规护理对精神分裂症患者的有效性。
我们检索了Cochrane精神分裂症研究组注册库(2006年9月),该注册库基于对BIOSIS、CENTRAL、CINAHL、EMBASE、MEDLINE和PsycINFO的定期检索。我们检查了所有已识别研究的参考文献以寻找进一步的试验。
我们纳入了所有将解决问题疗法与其他类似疗法或常规护理进行比较的临床随机试验。
我们独立提取数据。对于同质二分数据,我们基于意向性分析计算随机效应、相对风险(RR)、95%置信区间(CI),并在适当情况下计算治疗所需人数(NNT)。对于连续数据,我们使用随机效应统计模型计算加权平均差(WMD)。
我们仅纳入了三项小型试验(n = 52),这些试验评估了解决问题疗法与常规护理、应对技能训练或非特异性互动的对比。数据报告不充分使得许多结果无法使用。我们无法进行荟萃分析。总体结果有限且无定论,治疗组在住院、精神状态、行为、社交技能或提前退出研究方面没有显著差异。未提供关于整体状态、生活质量或满意度的数据。
我们发现没有足够的证据来证实或反驳解决问题疗法作为精神分裂症患者附加治疗方法的益处。参与者数量少、方法和结果的报告质量令人担忧。需要更多试验,充分报告方法以尽量减少偏倚,具备足够的样本量,采用经过验证、可靠且具有临床意义的结果,以提供有力证据来指导政策和实践。